ELIZABETH LANGLOIS: Open Payments
NPI 1508835570 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,006 in 63 payments from 17 companies in 2025. Trend: 2023 $1,371 · 2024 $2,072 · 2025 $2,006
Food & beverage: $2,006
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 12 | $528 |
| BridgeBio Pharma, Inc. | 7 | $230 |
| Novartis Pharmaceuticals Corporation | 5 | $161 |
| Edwards Lifesciences Corporation | 3 | $159 |
| Merck Sharp & Dohme LLC | 7 | $155 |
| ABIOMED | 2 | $151 |
| Actelion Pharmaceuticals US, Inc. | 4 | $137 |
| Amgen Inc. | 5 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $92 |
Products named: Attruby, CARDIOMEMS, LEQVIO, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, TRICLIP, VERQUVO, REPATHA, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
